Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
CytomX Therapeutics (CTMX) Ownership - Who Owns CytomX Therapeutics?
535 Followers
CytomX Therapeutics (CTMX) Ownership Overview
44.25% Insiders
7.69% Mutual Funds
37.91% Other Institutional Investors
10.14% Public Companies and
Individual Investors
The ownership structure of CytomX Therapeutics (CTMX) stock is a mix of institutional, retail and individual investors. Approximately 45.61% of the company’s stock is owned by Institutional Investors, 44.25% is owned by Insiders and 10.14% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 21, 2024 | Sold | $6180 | |
| Mar 21, 2024 | Sean A. Mccarthy Ceo,director | Sold | $42064 |
| Mar 21, 2024 | Sold | $10957 | |
| Mar 21, 2024 | Marcia Belvin Svp, Chief Scientific Officer | Sold | $26614 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,166,953 | Institution | 4.06% | 4,212,047 | |
| 3,132,025 | Institution | 4.02% | 4,165,593 | |
| 820,461 | Institution | 1.05% | 1,091,213 | |
| 647,886 | Institution | 0.83% | 861,688 | |
| 555,119 | Institution | 0.71% | 738,308 | |
| 443,224 | Institution | 0.57% | 589,488 | |
| 258,001 | Institution | 0.33% | 343,141 | |
| 149,399 | Institution | 0.19% | 198,701 | |
| 119,373 | Institution | 0.15% | 158,766 | |
| 106,678 | Institution | 0.14% | 141,882 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,132,025 | Institution | 4.02% | 4,165,593 | |
| 820,461 | Institution | 1.05% | 1,091,213 | |
| 647,886 | Institution | 0.83% | 861,688 | |
| 555,119 | Institution | 0.71% | 738,308 | |
| 443,224 | Institution | 0.57% | 589,488 | |
| 106,678 | Institution | 0.14% | 141,882 | |
| 51,570 | Institution | 0.07% | 68,588 | |
| 46,219 | Institution | 0.06% | 61,471 | |
| 44,926 | Institution | 0.06% | 59,752 | |
| 41,458 | Institution | 0.05% | 55,139 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,185,462 | Institution | 2.80% | 3,715,285 | |
| 981,491 | Institution | 1.26% | 1,668,535 | |
| 258,001 | Institution | 0.33% | 314,761 | |
| 149,399 | Institution | 0.19% | 198,701 | |
| 119,373 | Institution | 0.15% | 150,410 | |
| 23,094 | Institution | 0.03% | 28,175 | |
| 5 | Institution | <0.01% | 9 |
FAQ
Who Owns CytomX Therapeutics Inc (CTMX)?
According to the latest TipRanks data, approximately 37.91% of the company's stock is held by institutional investors, 44.25% is held by insiders, and 10.14% is held by retail investors.
What percentage of CytomX Therapeutics Inc (CTMX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.91% of CytomX Therapeutics Inc (CTMX) stock is held by institutional investors.
What percentage of CytomX Therapeutics Inc (CTMX) stock is held by retail investors?
According to the latest TipRanks data, approximately 10.14% of CytomX Therapeutics Inc (CTMX) stock is held by retail investors.
Who owns the most shares of CytomX Therapeutics Inc (CTMX)?
Vanguard owns the most shares of CytomX Therapeutics Inc (CTMX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.